{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:28:09Z","timestamp":1771464489557,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,12,8]],"date-time":"2007-12-08T00:00:00Z","timestamp":1197072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00192-007-0512-8","type":"journal-article","created":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T04:28:15Z","timestamp":1197001695000},"page":"701-704","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of tolterodine in relation to different urodynamic findings of detrusor overactivity"],"prefix":"10.1007","volume":"19","author":[{"given":"Stefano","family":"Salvatore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Serati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Alessandro","family":"Digesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Triacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vik","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PierFrancesco","family":"Bolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,8]]},"reference":[{"key":"512_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"key":"512_CR2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306\u201314 (discussion 1314\u20131315)","journal-title":"Eur Urol"},{"key":"512_CR3","first-page":"1606","volume-title":"Incontinence, 3rd International Consultation on Incontinence","author":"P Abrams","year":"2005","unstructured":"Abrams P, Andersson KE, Brubaker L, Cardozo L (2005) Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence, 3rd International Consultation on Incontinence. Plymbridge Distributors Ltd., Plymouth, UK, pp 1606\u20131608"},{"key":"512_CR4","doi-asserted-by":"crossref","unstructured":"Hay-Smith J, Herbison P, Ellis G, Morris A. (2005) Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev. Issue 3","DOI":"10.1002\/14651858.CD005429"},{"key":"512_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2005.02.024","volume":"48","author":"C Chapple","year":"2005","unstructured":"Chapple C, Khullar V, Gabriel Z, Dooley JA (2005) The effects of antimuscarinic treatments in Overactive Bladder: a systematic review and meta-analysis. Eur Urol 48:5\u201326","journal-title":"Eur Urol"},{"key":"512_CR6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1742-1241.2006.00986.x","volume":"60","author":"V Elinoff","year":"2006","unstructured":"Elinoff V, Bavendam T, Glasser DB, Carlsson M, Eyland N, Roberts R (2006) Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial. Int J Clin Pract 60:745\u2013751","journal-title":"Int J Clin Pract"},{"key":"512_CR7","first-page":"5","volume-title":"Incontinence, 2nd International Consultation on Incontinence","author":"J Morrison","year":"2002","unstructured":"Morrison J, Steers WD, Brading A, Blok B, Fry C, DeGroat WC, Kakizaki H, Levin R, Thor K (2002) Neurophysiology and neuropharmacology. In: Abrams P, Khoury S, Wein A (eds) Incontinence, 2nd International Consultation on Incontinence. Plymbridge Distributors Ltd., Plymouth, UK, p 5"},{"key":"512_CR8","first-page":"253","volume":"45","author":"KE Anderson","year":"1993","unstructured":"Anderson KE (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45:253\u2013308","journal-title":"Pharmacol Rev"},{"key":"512_CR9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0773.1992.tb00466.x","volume":"70","author":"KE Andersson","year":"1992","unstructured":"Andersson KE (1992) Clinical pharmacology of potassium channel openers. Pharmacol Toxicol 70:244\u2013254","journal-title":"Pharmacol Toxicol"},{"key":"512_CR10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0702358","volume":"126","author":"Y Igawa","year":"1999","unstructured":"Igawa Y, Yamazaki Y, Takeda H, Hayakawa K, Akahane M, Ajisawa Y (1999) Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 126:819","journal-title":"Br J Pharmacol"},{"key":"512_CR11","first-page":"479","volume-title":"Incontinence, 2nd International Consultation on Incontinence","author":"KE Andersson","year":"2002","unstructured":"Andersson KE, Appel R, Awad S, Chapple C, Drutz H, Fourcroy J (2002) Pharmacological treatment of urinary incontinence. In: Abrams P, Khoury S, Wein A (eds) Incontinence, 2nd International Consultation on Incontinence. Plymbridge Distributors Ltd., Plymouth, UK, p 479"},{"key":"512_CR12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0306-3623(94)90049-3","volume":"25","author":"A Szallasi","year":"1994","unstructured":"Szallasi A (1994) The vanilloid (capsaicin) receptor: receptor types and species differences. Gen Pharmacol 25:223","journal-title":"Gen Pharmacol"},{"key":"512_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/nau.10099","volume":"22","author":"GA Digesu","year":"2003","unstructured":"Digesu GA, Khullar V, Cardozo L, Salvatore S (2003) Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn 22:105\u2013108","journal-title":"Neurourol Urodyn"},{"key":"512_CR14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1471-0528.2003.02081.x","volume":"110","author":"GA Digesu","year":"2003","unstructured":"Digesu GA, Hutchings A, Salvatore S, Selvaggi L, Khullar V (2003) Pressure flow parameters in female: reliability studies. BJOG 110:774\u2013776","journal-title":"BJOG"},{"key":"512_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","volume":"21","author":"W Schafer","year":"2002","unstructured":"Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261\u2013274","journal-title":"Neurourol Urodyn"},{"key":"512_CR16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/nau.20243","volume":"25","author":"KL Burgio","year":"2006","unstructured":"Burgio KL, Goode PS, Richter HE, Locher JL, Roth DL (2006) Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings. Neurourol Urodyn 25:411\u2013417","journal-title":"Neurourol Urodyn"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-007-0512-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-007-0512-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-007-0512-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:50:44Z","timestamp":1558608644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-007-0512-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,8]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1007\/s00192-007-0512-8","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,8]]}}}